solution by Industry

Complete GMP Production Lines for Oral Solid Dosage Manufacturing

From granulation and tableting to coating, capsule filling, and packaging — turnkey OSD plant solutions engineered for global regulatory approval.

Industry Overview

The Industry at a Glance

The global oral solid dosage pharmaceutical market is valued at USD 651.2 billion in 2025 and is projected to reach USD 1,211.0 billion by 2035, advancing at a CAGR of 6.4%. Growth is driven by the increasing need for convenient, patient-friendly medications and a rising prevalence of chronic diseases requiring long-term oral therapy. Accelerated adoption of continuous manufacturing and patent-cliff-driven reformulations are sustaining expansion, creating significant opportunities for pharmaceutical manufacturers investing in new or upgraded OSD production capacity — particularly across emerging markets in Asia-Pacific, Africa, and Latin America.

Product Applications

Where Our Products Are Used

  • 1

    IV Infusion Production Lines

    Complete systems for Non-PVC soft bag, PP bottle, and glass bottle IV solutions, from compounding to filling and sterilization.
  • 2

    Ampoule & Vial Filling Lines

    High-speed aseptic filling and sealing lines for injectable formulations, fully compliant with cGMP requirements.
  • 3

    Oral Solid Dosage (OSD) Plants

    Integrated granulation, tablet pressing, capsule filling, coating, and blister packaging for tablets and capsules.
  • 4

    Pharmaceutical Water Treatment Systems

    Purified water (PW) and water for injection (WFI) generation, storage, and distribution systems meeting pharmacopeia standards.
  • 5

    Cleanroom & HVAC Engineering

    Full facility design including classified cleanrooms, HVAC zoning, and environmental monitoring systems.

technology

Pain Points & Solutions

  • Pain Point: Coordinating multiple vendors for granulation, tableting, coating, and packaging creates integration gaps and validation delays.

    Solution: Single-source turnkey OSD plant delivery — from process design through equipment manufacturing, installation, and full IQ/OQ/PQ validation under one contract.

  • Pain Point: Navigating diverse GMP standards across target export markets extends time to certification.

    Solution: All systems pre-engineered to meet EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP simultaneously — built for multi-market approval readiness.

  • Pain Point: Dust containment and cross-contamination control in OSD facilities pose significant compliance risks.

    Solution: Dedicated cleanroom design with negative-pressure cascading, dust extraction, and segregated HVAC zones tailored to OSD and HPAPI handling requirements.

  • Pain Point: Scaling from small-batch to commercial-volume production without costly facility redesign.

    Solution: Modular, expandable line architecture enabling seamless capacity scale-up with validated process parameters.

Advantages

Why Choose Us

  • 2,500+ production lines delivered in 60+ countries — proven global OSD project execution

  • 40+ turnkey pharmaceutical factories completed end-to-end, from concept to commercial production

  • Multi-standard GMP compliance (EU, FDA, WHO, PIC/S) engineered into every system

  • 4 self-owned factories for pharma machinery, water treatment, cleanroom, and packaging — full vertical integration

  • Full lifecycle services — consulting, process design, equipment manufacturing, installation, validation, tech transfer, and operator training

  • Customized OSD configurations — from single tableting lines to complete multi-dosage-form factories

case

Success Snapshot

  • Generic Pharmaceutical Manufacturer

    West Africa

    Delivered a complete OSD turnkey factory including tablet and capsule lines, purified water system, cleanroom, and packaging. The facility achieved WHO GMP prequalification on its first inspection and reached annual output of 800 million tablets and 200 million capsules within the first year of operation.

  • Growing Pharma Company

    Central Asia

    Supplied an integrated tablet production line with granulation, compression, coating, and blister packaging. The project was completed in 14 months from contract to validated production, enabling the client to launch 12 generic OSD products for domestic and export markets.

testimony

Trusted by Industry Leaders

  • “IVEN handled everything — from our water system and cleanroom to the tableting and packaging lines. One partner, one responsibility, zero coordination headaches. We passed WHO GMP prequalification ahead of schedule.”

    Mr. D

    CEO

  • “Their team understood our local regulatory requirements and designed the entire facility accordingly. The technology transfer and staff training were exceptionally thorough — our operators were production-ready on day one.”

    Mrs. S

    Plant Director

Support

FAQ

Our systems support tablets (film-coated, sugar-coated, enteric-coated, sustained-release, effervescent), hard capsules, pellets, and granules across a wide range of therapeutic categories.

Yes. We design OSD facilities with appropriate containment levels, including isolator integration, closed-system material handling, and negative-pressure cleanroom zones for potent compound processing.

All projects are designed to simultaneously satisfy EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP requirements for multi-market export readiness.

Most complete OSD factory projects are delivered within 12–20 months from contract signing to validated commercial production, depending on scope and complexity.

Yes — including preventive maintenance programs, remote technical support, spare parts supply, process optimization, and on-site service visits.

Related Industry Solutions